Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multicentric Castleman's disease].

E Borgen, P F Marton

    Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
    |January 20, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).

    ESMO open·2024
    Same author

    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Single cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring.

    Scientific reports·2015
    Same author

    Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.

    British journal of cancer·2014
    Same author

    Clinical significance of disseminated tumour cells in non-small cell lung cancer.

    British journal of cancer·2013
    Same author

    Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.

    Breast cancer research and treatment·2013
    Same journal

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    Same journal

    Correction: Management of acute epistaxis.

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    Same journal

    A woman in her 70s with chest pain and elevated troponin T levels.

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    Same journal

    More systematic follow-up after childbirth.

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    Same journal

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    Same journal

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    See all related articles

    This case study details a fatal outcome for a 68-year-old man with multicentric Castleman's disease, highlighting severe hemolytic anemia. The findings underscore the distinct nature of multicentric Castleman's disease compared to its localized form.

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Castleman's disease is a rare lymphoproliferative disorder with two main variants: localized and multicentric.
    • Multicentric Castleman's disease (MCD) is a systemic illness often associated with significant morbidity and mortality.

    Observation:

    • A 68-year-old male presented with histologically confirmed multicentric Castleman's disease.
    • The patient's clinical presentation was primarily characterized by severe hemolytic anemia.
    • Despite aggressive therapeutic interventions, the patient's outcome was unfortunately fatal.

    Findings:

    • Multicentric Castleman's disease presented with distinct epidemiological and clinical features compared to the localized form.
    • Severe hemolytic anemia was a dominant clinical manifestation in this MCD case.

    Related Experiment Videos

  • The distinct characteristics suggest that localized and multicentric Castleman's disease are separate clinicopathological entities.

    • Implications:

    • Understanding the differences between MCD and localized Castleman's disease is crucial for accurate diagnosis and management.
    • The case highlights the aggressive nature of MCD and the challenges in treatment, particularly when complicated by severe hemolytic anemia.
    • Further research into the distinct pathophysiology and treatment strategies for MCD is warranted.